Patricio Rojas‐Silva
Patricio Rojas‐Silva publishes mostly in Infectious Diseases, Molecular Biology and Plant Science, on topics such as SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Research on Leishmaniasis Studies.
- World rank
- #927,187 of 7,710,434 ranked researchers
- Rank in Ecuador
- #172 of 6,574
- Works
- 45
- Citations
- 3.7k
- Citations per work
- 81.6
What does Patricio Rojas‐Silva research?
Patricio Rojas‐Silva's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (13%), Agricultural and Biological Sciences (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1839.7%
- Medicine1839.7%
- Everything else1431.4%
- Life Sciences1023.1%
- Physical Sciences35.8%
- Chemistry35.8%
- 1Infectious Diseases26% of their works
- 2Molecular Biology13% of their works
- 3Plant Science10% of their works
- 4Public Health, Environmental and Occupational Health8% of their works
- 5Organic Chemistry6% of their works
- 6Epidemiology5% of their works
Research topics
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Research on Leishmaniasis Studies
- SARS-CoV-2 detection and testing
- Moringa oleifera research and applications
- Genomics, phytochemicals, and oxidative stress
- Phytochemicals and Antioxidant Activities
- Trypanosoma species research and implications
Which keywords describe Patricio Rojas‐Silva's research?
The keywords of their largest research topics: SARS-CoV-2, ACE2 Receptor, Pandemic, Immunity, Epidemiology, Coronavirus, Vaccine and Drug Resistance.
- Nrf2
- Free Radicals
- Antioxidants
- Antioxidant Properties
- COVID-19
- Oxidative Stress
- Thrombosis
- Drug Resistance
- Coronavirus
- Immunity
- ACE2 Receptor
- SARS-CoV-2
- Pandemic
- Epidemiology
- Vaccine
- Clinical Characteristics
- Leishmaniasis
- Treatment
- Diagnostics
- Moringa oleifera
- Chagas Disease
- Keap1-Nrf2-ARE Pathway
- Trypanosoma cruzi
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- SARS-CoV-2313 topics
- ACE2 Receptor252 topics
- Pandemic252 topics
- Immunity242 topics
- Epidemiology213 topics
- Coronavirus161 topic
- Vaccine161 topic
- Drug Resistance122 topics
- Clinical Characteristics91 topic
- Thrombosis91 topic
- Leishmaniasis81 topic
- Oxidative Stress82 topics
- Treatment81 topic
- COVID-1961 topic
- Diagnostics61 topic
- Antioxidant Properties51 topic
- Moringa oleifera51 topic
- Antioxidants41 topic
- Chagas Disease41 topic
- Free Radicals41 topic
- Keap1-Nrf2-ARE Pathway41 topic
- Nrf241 topic
- Trypanosoma cruzi41 topic
Where does Patricio Rojas‐Silva work?
Patricio Rojas‐Silva's main affiliation in the publication record is Universidad San Francisco de Quito, Ecuador.
How many publications and citations does Patricio Rojas‐Silva have?
OpenAlex counts 45 works and 3,673 citations for Patricio Rojas‐Silva, an h-index of 19, ranking #927,187 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Patricio Rojas‐Silva. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.